Core Alternative Capital’s Teladoc Health TDOC Stock Holding History

Core Alternative Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23	Closed	-$1K	–	437
2022 Q3	$1K	Buy	+23	New	+$807	﹤0.01%	431
2022 Q1	–	Sell	-22	Closed	-$2K	–	481
2021 Q4	$2K	Buy	+22	New	+$2.63K	﹤0.01%	335

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Core Alternative Capital's TDOC Position: Q4 2022 in Review

Core Alternative Capital sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 23 shares — an estimated $1K sold.

Core Alternative Capital first reported a position in TDOC in Q4 2021 and held it in 2 quarters. The position peaked at $2K in Q4 2021. 444 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

Core Alternative Capital reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
Core Alternative Capital sold 23 Teladoc Health shares in Q4 2022, an estimated $1K.
Core Alternative Capital first reported a position in Teladoc Health in Q4 2021 and held it in 2 quarters.
Core Alternative Capital's Teladoc Health position peaked at $2K in Q4 2021.
444 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Core Alternative Capital's 13F filing for Q4 2022, filed 31 Jan 2023.